Opie-Martin, Sarah
Iacoangeli, Alfredo https://orcid.org/0000-0002-5280-5017
Topp, Simon D. https://orcid.org/0000-0002-5200-3284
Abel, Olubunmi
Mayl, Keith
Mehta, Puja R. https://orcid.org/0000-0002-0255-407X
Shatunov, Aleksey
Fogh, Isabella
Bowles, Harry
Limbachiya, Naomi https://orcid.org/0000-0002-0200-4676
Spargo, Thomas P.
Al-Khleifat, Ahmad https://orcid.org/0000-0002-7406-9831
Williams, Kelly L. https://orcid.org/0000-0001-6319-9473
Jockel-Balsarotti, Jennifer
Bali, Taha
Self, Wade https://orcid.org/0000-0003-1648-6124
Henden, Lyndal https://orcid.org/0000-0001-5541-7637
Nicholson, Garth A. https://orcid.org/0000-0001-9694-066X
Ticozzi, Nicola https://orcid.org/0000-0001-5963-7426
McKenna-Yasek, Diane
Tang, Lu
Shaw, Pamela J. https://orcid.org/0000-0002-8925-2567
Chio, Adriano
Ludolph, Albert
Weishaupt, Jochen H.
Landers, John E. https://orcid.org/0000-0001-8084-5043
Glass, Jonathan D. https://orcid.org/0000-0002-3295-4971
Mora, Jesus S. https://orcid.org/0000-0001-6633-5354
Robberecht, Wim
Damme, Philip Van https://orcid.org/0000-0002-4010-2357
McLaughlin, Russell https://orcid.org/0000-0003-3915-2135
Hardiman, Orla
van den Berg, Leonard
Veldink, Jan H. https://orcid.org/0000-0001-5572-9657
Corcia, Phillippe
Stevic, Zorica
Siddique, Nailah
Silani, Vincenzo
Blair, Ian P.
Fan, Dong-sheng
Esselin, Florence
de la Cruz, Elisa https://orcid.org/0000-0003-3345-1628
Camu, William https://orcid.org/0000-0003-1287-7355
Basak, Nazli A.
Siddique, Teepu https://orcid.org/0000-0001-7293-9146
Miller, Timothy
Brown, Robert H. https://orcid.org/0000-0001-6062-1528
Al-Chalabi, Ammar https://orcid.org/0000-0002-4924-7712
Shaw, Christopher E.
Article History
Received: 1 February 2022
Accepted: 31 October 2022
First Online: 12 November 2022
Change Date: 2 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-49938-y
Competing interests
: J.H.V. reports to have sponsored research agreements with Biogen. P.V.D. holds a senior clinical investigatorship of FWO-Vlaanderen and is supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the ALS Liga België and the KU Leuven funds “Een Hart voor ALS”, “Laeversfonds voor ALS Onderzoek” and the “Valéry Perrier Race against ALS Fund”. Several authors of this publication (A.C., A.L., J.W., L.B., O.H., V.S.) are members of the European Reference Network for Rare Neuromuscular Diseases (ERN-NMD). The remaining authors declare no conflicts of interest.